Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03600350
Title pTVG-HP and Nivolumab in Patients With Non-Metastatic PSA-Recurrent Prostate Cancer
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Indications

prostate adenocarcinoma

Therapies

Nivolumab + pTVG-HP plasmid DNA vaccine + Sargramostim

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.